Supplemental material
Journal of Chemotherapy
Volume 35, 2023 - Issue 8
Antimicrobial Original Research Paper
Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019)
M. A. Pfallera JMI Laboratories, North Liberty, IA, USA;b Department of Pathology, University of Iowa College of Medicine, Iowa City, IA, USA
https://orcid.org/0000-0003-4501-6068View further author information
https://orcid.org/0000-0003-4501-6068View further author information, R. E. Mendesa JMI Laboratories, North Liberty, IA, USAhttps://orcid.org/0000-0002-8648-1137View further author information
https://orcid.org/0000-0002-8648-1137View further author information, H. S. Sadera JMI Laboratories, North Liberty, IA, USAhttps://orcid.org/0000-0001-7022-6644View further author information
https://orcid.org/0000-0001-7022-6644View further author information, M. Castanheiraa JMI Laboratories, North Liberty, IA, USAhttps://orcid.org/0000-0003-0126-1782View further author information
https://orcid.org/0000-0003-0126-1782View further author information & C. G. Carvalhaesa JMI Laboratories, North Liberty, IA, USACorrespondence[email protected]
https://orcid.org/0000-0002-2734-3754View further author information
https://orcid.org/0000-0002-2734-3754View further author information